Chennai, Tamil Nadu: Lubrizol and Polyhose have inaugurated a new medical tubing manufacturing facility in Chennai, marking a significant step toward strengthening India’s medical technology and healthcare ecosystem.
The advanced manufacturing site will produce precision extruded medical tubing for minimally invasive neurovascular and cardiovascular devices, supporting the country’s growing demand for high-quality medical technologies.
The new facility combines Lubrizol’s expertise in medical device materials and innovation with Polyhose’s manufacturing capabilities in fluid conveyance systems.
The collaboration is expected to enhance regional production capacity, improve supply reliability, and support customers in India as well as global markets.
Speaking at the inauguration, John Valukas, President, Lubrizol Engineered Materials, said, “Today’s inauguration is an important milestone in Lubrizol’s commitment to India and to supporting our customers in the global medical device industry.
By combining Lubrizol’s medical device expertise with the manufacturing strength of local partners in India, this facility will deliver advanced tubing solutions for life-saving neurovascular and cardiovascular applications.
Our goal is to help our customers bring these critical technologies to patients faster, with reliable local supply and the highest quality standards.”
The newly established medical tubing facility has been designed as a world-class operation and is certified under ISO 13485 standards.
It is equipped with dedicated quality control systems and follows the same stringent manufacturing standards applied across Lubrizol’s global production network.
The investment is expected to strengthen the company’s ability to serve customers in India while also supporting demand from international markets.
The facility’s operations will focus on producing precision extruded medical tubing using a range of high-performance materials. These include polyamides, nylon, Pebax, polypropylene, polyethylene, and Lubrizol’s medical-grade thermoplastic polyurethane (TPU). Such materials are widely used in advanced medical devices that require flexibility, durability, and precision.
Abhishek Shrivastava, Managing Director, Lubrizol IMEA, highlighted India’s growing importance within the company’s global strategy. He said, “India is a strategic growth market for Lubrizol and a key hub for our investments in manufacturing, R&D and technical services.
This medical manufacturing site in Chennai is another step in building a stronger local ecosystem for high-value, technology-driven products.
By working closely with Polyhose and regional stakeholders, we aim to support innovation, create high-skilled jobs and enable India to become a more significant contributor to the global medical device supply chain.”
The establishment of the medical tubing manufacturing site aligns with broader efforts to strengthen domestic manufacturing capabilities and support the expansion of India’s MedTech sector.
The facility is expected to contribute to innovation, employment generation, and the development of a more resilient healthcare manufacturing ecosystem.
Also Read: HyperNext Selects KOEL’s Optiprime Power Solutions for 192 MW Hyperscale Data Centre Deployment
Mittal Shah, Business Head, Medical Devices IMEA, Lubrizol, emphasized the growing role of minimally invasive procedures in modern healthcare. He said, “Minimally invasive procedures are transforming patient care, and high-precision tubing is at the heart of many of these devices.
With this Chennai site, we are bringing world-class catheter tubing capabilities closer to our customers in India and across IMEA. This partnership with Polyhose will enable a broad range of devices utilizing high-performance materials, further strengthening our ability to partner with medical device OEMs in India across the full product development lifecycle.”
As demand for advanced medical devices continues to rise, the availability of locally manufactured medical tubing is expected to provide device manufacturers with improved access to critical components while reducing supply chain complexities.
Shabbir Yusuf Jamnagarwala, Founder & Managing Director, Polyhose, said, “For more than three decades, Polyhose has partnered with global customers by delivering innovative extrusion and fluid conveyance solutions. Our collaboration with Lubrizol marks a new chapter in our journey, combining Polyhose’s world-class manufacturing strengths with Lubrizol’s deep materials science and medical device expertise to deliver advanced medical tubing solutions for the rapidly evolving healthcare industry.
This investment reflects our commitment to innovation, creating skilled employment opportunities, and strengthening India’s position as a trusted global hub for advanced medical device manufacturing.”
The new facility is expected to expand India’s production capacity for medical tubing, supporting the country’s objective of strengthening domestic medical device manufacturing, reducing dependence on imports, and improving patient access to safe, high-quality healthcare products.
The investment also reinforces India’s growing role in the global medical device supply chain and its emergence as a destination for advanced healthcare manufacturing.
